{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:19:54Z","timestamp":1790867994739,"version":"4.1.0"},"reference-count":53,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The loss of the retinoblastoma tumor suppressor gene (RB) is common in many human cancers, including prostate. We previously reported that engineered deletion of RB in prostate epithelial cells results in sustained cell growth in serum-free media, a predisposition to develop hyperplasia and dysplasia in prostate tissue recombinant grafts, and sensitization to hormonal carcinogenesis. Examining the molecular consequence of RB loss in this system, we show that cyclooxygenase-2 (COX-2) is significantly up-regulated following RB deletion in prostate tissue recombinants. To study the effect of RB deletion on COX-2 regulation, we generated wild-type (PrE) and Rb\u2212\/\u2212 (Rb\u2212\/\u2212PrE) prostate epithelial cell lines rescued by tissue recombination. We show elevated COX-2 mRNA and protein expression in Rb\u2212\/\u2212PrE cell lines with increased prostaglandin synthesis. We also find that loss of Rb leads to deregulated E2F activity, with increased expression of E2F target genes, and that exogenous expression of E2F1 results in elevated COX-2 mRNA and protein levels. COX-2 promoter studies reveal that E2F1 transcriptionally activates COX-2, which is dependent on the transactivation and DNA-binding domains of E2F1. Further analysis revealed that the E2F1 target gene, c-myb, is elevated in Rb\u2212\/\u2212PrE cells and E2F1-overexpressing cells, whereas ectopic overexpression of c-myb activates the COX-2 promoter in prostate epithelial cells. Additionally, cotransfection with E2F1 and a dominant-negative c-myb inhibited E2F1 activation of the COX-2 promoter. Taken together, these results suggest activation of a transcriptional cascade by which E2F1 regulates COX-2 expression through the c-myb oncogene. This study reports a novel finding describing that deregulation of the Rb\/E2F complex results in increased COX-2 expression and activity.<\/jats:p>","DOI":"10.1158\/0008-5472.can-04-3129","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T21:37:43Z","timestamp":1126820263000},"page":"3633-3642","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Disruption of Rb\/E2F Pathway Results in Increased Cyclooxygenase-2 Expression and Activity in Prostate Epithelial Cells"],"prefix":"10.1158","volume":"65","author":[{"given":"Joanne N.","family":"Davis","sequence":"first","affiliation":[{"name":"1Department of Urology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"McCabe","sequence":"additional","affiliation":[{"name":"1Department of Urology and"},{"name":"2Program in Cellular and Molecular Biology, Michigan Urology Center, University of Michigan, Ann Arbor, Michigan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon W.","family":"Hayward","sequence":"additional","affiliation":[{"name":"3Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Park","sequence":"additional","affiliation":[{"name":"1Department of Urology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Day","sequence":"additional","affiliation":[{"name":"1Department of Urology and"},{"name":"2Program in Cellular and Molecular Biology, Michigan Urology Center, University of Michigan, Ann Arbor, Michigan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2005,5,2]]},"reference":[{"key":"2022061621040767200_B1","doi-asserted-by":"crossref","unstructured":"Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem\u20082000; 69: 145\u201382.","DOI":"10.1146\/annurev.biochem.69.1.145"},{"key":"2022061621040767200_B2","doi-asserted-by":"crossref","unstructured":"Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol\u20081998; 38: 97\u2013120.","DOI":"10.1146\/annurev.pharmtox.38.1.97"},{"key":"2022061621040767200_B3","unstructured":"Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res\u20081995; 55: 3785\u20139."},{"key":"2022061621040767200_B4","unstructured":"Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res\u20081998; 58: 4997\u20135001."},{"key":"2022061621040767200_B5","doi-asserted-by":"crossref","unstructured":"Nagai N, Tian X, Mukai K, et al. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy. Int J Mol Med\u20082003; 12: 709\u201314.","DOI":"10.3892\/ijmm.12.5.709"},{"key":"2022061621040767200_B6","doi-asserted-by":"crossref","unstructured":"Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst\u20081998; 90: 455\u201360.","DOI":"10.1093\/jnci\/90.6.455"},{"key":"2022061621040767200_B7","doi-asserted-by":"crossref","unstructured":"Fujita H, Koshida K, Keller ET, et al. Cyclooxygenase-2 promotes prostate cancer progression. Prostate\u20082002; 53: 232\u201340.","DOI":"10.1002\/pros.10152"},{"key":"2022061621040767200_B8","doi-asserted-by":"crossref","unstructured":"Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc \u03b4716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell\u20081996; 87: 803\u20139.","DOI":"10.1016\/S0092-8674(00)81988-1"},{"key":"2022061621040767200_B9","unstructured":"Chulada PC, Thompson MB, Mahler JF, et al. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res\u20082000; 60: 4705\u20138."},{"key":"2022061621040767200_B10","doi-asserted-by":"crossref","unstructured":"Gupta S, Srivastava M, Ahmad N, Bostwick DG, Mukhtar H. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate\u20082000; 42: 73\u20138.","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G"},{"key":"2022061621040767200_B11","doi-asserted-by":"crossref","unstructured":"Yoshimura R, Sano H, Masuda C, et al. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer\u20082000; 89: 589\u201396.","DOI":"10.1002\/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C"},{"key":"2022061621040767200_B12","doi-asserted-by":"crossref","unstructured":"Madaan S, Abel PD, Chaudhary KS, et al. Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment. BJU Int\u20082000; 86: 736\u201341.","DOI":"10.1046\/j.1464-410x.2000.00867.x"},{"key":"2022061621040767200_B13","unstructured":"Zha S, Gage WR, Sauvageot J, et al. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Cancer Res\u20082001; 61: 8617\u201323."},{"key":"2022061621040767200_B14","unstructured":"Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-\u03b1 in normal and malignant prostate cells. Cancer Res\u20082001; 61: 2720\u20136."},{"key":"2022061621040767200_B15","doi-asserted-by":"crossref","unstructured":"Wang W, Bergh A, Damber JE. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. Prostate\u20082004; 61: 60\u201372.","DOI":"10.1002\/pros.20061"},{"key":"2022061621040767200_B16","doi-asserted-by":"crossref","unstructured":"Gupta S, Adhami VM, Subbarayan M, et al. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res\u20082004; 64: 3334\u201343.","DOI":"10.1158\/0008-5472.CAN-03-2422"},{"key":"2022061621040767200_B17","unstructured":"Shappell SB, Olson SJ, Hannah SE, et al. Elevated expression of 12\/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Res\u20082003; 63: 2256\u201367."},{"key":"2022061621040767200_B18","doi-asserted-by":"crossref","unstructured":"Phillips SM, Morton DG, Lee SJ, Wallace DM, Neoptolemos JP. Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Br J Urol\u20081994; 73: 390\u20135.","DOI":"10.1111\/j.1464-410X.1994.tb07602.x"},{"key":"2022061621040767200_B19","doi-asserted-by":"crossref","unstructured":"Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen K. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur J Cancer\u20081995; 31A: 329\u201333.","DOI":"10.1016\/0959-8049(94)00463-F"},{"key":"2022061621040767200_B20","doi-asserted-by":"crossref","unstructured":"Gope R, Gope ML. Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer. Mol Cell Biochem\u20081992; 110: 123\u201333.","DOI":"10.1007\/BF02454189"},{"key":"2022061621040767200_B21","unstructured":"Primdahl H, von der Maase H, Christensen M, Wolf H, Orntoft TF. Allelic deletions of cell growth regulators during progression of bladder cancer. Cancer Res\u20082000; 60: 6623\u20139."},{"key":"2022061621040767200_B22","unstructured":"Nevins JR. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ\u20081998; 9: 585\u201393."},{"key":"2022061621040767200_B23","doi-asserted-by":"crossref","unstructured":"Sherr CJ. Cancer cell cycles. Science\u20081996; 274: 1672\u20137.","DOI":"10.1126\/science.274.5293.1672"},{"key":"2022061621040767200_B24","doi-asserted-by":"crossref","unstructured":"Pierce AM, Gimenez-Conti IB, Schneider-Broussard R, Martinez LA, Conti CJ, Johnson DG. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci U S A\u20081998; 95: 8858\u201363.","DOI":"10.1073\/pnas.95.15.8858"},{"key":"2022061621040767200_B25","doi-asserted-by":"crossref","unstructured":"Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, Russell JL, Conti CJ, Johnson DG. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol\u20081999; 19: 6408\u201314.","DOI":"10.1128\/MCB.19.9.6408"},{"key":"2022061621040767200_B26","doi-asserted-by":"crossref","unstructured":"Pierce AM, Fisher SM, Conti CJ, Johnson DG. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene\u20081998; 16: 1267\u201376.","DOI":"10.1038\/sj.onc.1201666"},{"key":"2022061621040767200_B27","unstructured":"Zhang SY, Liu SC, Johnson DG, Klein-Szanto AJ. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res\u20082000; 60: 5972\u20136."},{"key":"2022061621040767200_B28","unstructured":"Zhang SY, Liu SC, Al-Saleem LF, et al. E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev\u20082000; 9: 395\u2013401."},{"key":"2022061621040767200_B29","doi-asserted-by":"crossref","unstructured":"Gorgoulis VG, Zacharatos P, Mariatos G, et al. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J Pathol\u20082002; 198: 142\u201356.","DOI":"10.1002\/path.1121"},{"key":"2022061621040767200_B30","doi-asserted-by":"crossref","unstructured":"Etges A, Nunes FD, Ribeiro KC, Araujo VC. Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumours. Oral Oncol\u20082004; 40: 326\u201331.","DOI":"10.1016\/j.oraloncology.2003.08.021"},{"key":"2022061621040767200_B31","doi-asserted-by":"crossref","unstructured":"Ma Y, Croxton R, Moorer RL Jr, Cress WD. Identification of novel E2F1-regulated genes by microarray. Arch Biochem Biophys\u20082002; 399: 212\u201324.","DOI":"10.1006\/abbi.2002.2761"},{"key":"2022061621040767200_B32","doi-asserted-by":"crossref","unstructured":"Day KC, McCabe MT, Zhao X, et al. Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis. J Biol Chem\u20082002; 277: 44475\u201384.","DOI":"10.1074\/jbc.M205361200"},{"key":"2022061621040767200_B33","unstructured":"Wang Y, Hayward SW, Donjacour AA, et al. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res\u20082000; 60: 6008\u201317."},{"key":"2022061621040767200_B34","doi-asserted-by":"crossref","unstructured":"Liu CH, Chang SH, Narko K, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem\u20082001; 276: 18563\u20139.","DOI":"10.1074\/jbc.M010787200"},{"key":"2022061621040767200_B35","doi-asserted-by":"crossref","unstructured":"Tjandrawinata RR, Dahiya R, Hughes-Fulford M. Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Br J Cancer\u20081997; 75: 1111\u20138.","DOI":"10.1038\/bjc.1997.192"},{"key":"2022061621040767200_B36","doi-asserted-by":"crossref","unstructured":"Liu XH, Kirschenbaum A, Lu M, et al. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6\/GP130\/STAT-3 signaling pathway. Biochem Biophys Res Commun\u20082002; 290: 249\u201355.","DOI":"10.1006\/bbrc.2001.6188"},{"key":"2022061621040767200_B37","doi-asserted-by":"crossref","unstructured":"Macleod KF, Hu Y, Jacks T. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J\u20081996; 15: 6178\u201388.","DOI":"10.1002\/j.1460-2075.1996.tb01006.x"},{"key":"2022061621040767200_B38","doi-asserted-by":"crossref","unstructured":"Ruiz S, Santos M, Segrelles C, et al. Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development\u20082004; 131: 2737\u201348.","DOI":"10.1242\/dev.01148"},{"key":"2022061621040767200_B39","doi-asserted-by":"crossref","unstructured":"Neuman E, Flemington EK, Sellers WR, Kaelin WG Jr. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol\u20081994; 14: 6607\u201315.","DOI":"10.1128\/MCB.14.10.6607"},{"key":"2022061621040767200_B40","doi-asserted-by":"crossref","unstructured":"Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature\u20082003; 424: 223\u20138.","DOI":"10.1038\/nature01764"},{"key":"2022061621040767200_B41","unstructured":"Black EP, Huang E, Dressman H, et al. Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res\u20082003; 63: 3716\u201323."},{"key":"2022061621040767200_B42","doi-asserted-by":"crossref","unstructured":"Ishida S, Huang E, Zuzan H, et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol\u20082001; 21: 4684\u201399.","DOI":"10.1128\/MCB.21.14.4684-4699.2001"},{"key":"2022061621040767200_B43","unstructured":"Ramsay RG, Friend A, Vizantios Y, et al. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB. Cancer Res\u20082000; 60: 1805\u20139."},{"key":"2022061621040767200_B44","unstructured":"Sala A, Nicolaides NC, Engelhard A, et al. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Cancer Res\u20081994; 54: 1402\u20136."},{"key":"2022061621040767200_B45","doi-asserted-by":"crossref","unstructured":"Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem\u20082000; 275: 11397\u2013403.","DOI":"10.1074\/jbc.275.15.11397"},{"key":"2022061621040767200_B46","doi-asserted-by":"crossref","unstructured":"Nikolic D, van Breemen RB. DNA oxidation induced by cyclooxygenase-2. Chem Res Toxicol\u20082001; 14: 351\u20134.","DOI":"10.1021\/tx010004x"},{"key":"2022061621040767200_B47","doi-asserted-by":"crossref","unstructured":"Leung WK, To KF, Go MY, et al. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int J Oncol\u20082003; 23: 1317\u201322.","DOI":"10.3892\/ijo.23.5.1317"},{"key":"2022061621040767200_B48","doi-asserted-by":"crossref","unstructured":"Crawford YG, Gauthier ML, Joubel A, et al. Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell\u20082004; 5: 263\u201373.","DOI":"10.1016\/S1535-6108(04)00023-6"},{"key":"2022061621040767200_B49","doi-asserted-by":"crossref","unstructured":"Hurford RK Jr, Cobrinik D, Lee MH, Dyson N. pRB and p107\/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev\u20081997; 11: 1447\u201363.","DOI":"10.1101\/gad.11.11.1447"},{"key":"2022061621040767200_B50","doi-asserted-by":"crossref","unstructured":"Campanero MR, Armstrong M, Flemington E. Distinct cellular factors regulate the c-myb promoter through its E2F element. Mol Cell Biol\u20081999; 19: 8442\u201350.","DOI":"10.1128\/MCB.19.12.8442"},{"key":"2022061621040767200_B51","doi-asserted-by":"crossref","unstructured":"Slamon DJ, Boone TC, Murdock DC, et al. Studies of the human c-myb gene and its product in human acute leukemias. Science\u20081986; 233: 347\u201351.","DOI":"10.1126\/science.3014652"},{"key":"2022061621040767200_B52","doi-asserted-by":"crossref","unstructured":"Griffin CA, Baylin SB. Expression of the c-myb oncogene in human small cell lung carcinoma. Cancer Res\u20081985; 45: 272\u20135.","DOI":"10.1007\/978-3-642-82533-0_25"},{"key":"2022061621040767200_B53","doi-asserted-by":"crossref","unstructured":"Alitalo K, Winqvist R, Lin CC, de la Chapelle A, Schwab M, Bishop JM. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc Natl Acad Sci U S A\u20081984; 81: 4534\u20138.","DOI":"10.1073\/pnas.81.14.4534"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/9\/3633\/2864889\/3633-3642.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/9\/3633\/2864889\/3633-3642.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T22:17:52Z","timestamp":1655417872000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/9\/3633\/519684\/Disruption-of-Rb-E2F-Pathway-Results-in-Increased"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2005,5,2]]},"published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-04-3129","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}